While humanoid robots will not be replacing doctors anytime soon, a momentous technology-driven shift has already started in the medical sector. By the end of this decade, global healthcare systems could change dramatically.
In December 2023, the FDA approved the first CRISPR-based gene-editing therapy, CASGEVY. Gene editing has now crossed from concept to regulated medicine.
At the same time, biology is becoming more computable. AlphaFold 3 expanded structure prediction into broader biomolecular interactions. Moderna and Merck reported that their personalized mRNA cancer vaccine reduced recurrence or death in high-risk melanoma patients by half! Is there a potential for vaccines against cancer?
Which code-to-cure breakthroughs will reach patients first? What must happen in Europe for us to help build (and not just import) that future? We’ll explore these topics through the lens of computational biology, bioprocess engineering, medtech, and AI-to-clinic translation.
- Biotech
